Richard Anthony Cunningham - Dec 9, 2024 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Chief Executive Officer, Director
Signature
/s/ Daniel George, Attorney-in-Fact
Stock symbol
ANEB
Transactions as of
Dec 9, 2024
Transactions value $
$0
Form type
4
Date filed
12/10/2024, 09:00 AM
Previous filing
Oct 11, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +254K $0.00 254K Dec 9, 2024 Common Stock 254K $1.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the options vest immediately on the date of the grant.